The Multitasking Rehabilitation She Enhanced Walking Speed Compared to the Simple Post Stroke Rehabilitation Task (AVC)?

Overview

Stroke is the leading cause of severe disability in adults. The first cause of alterations in the quality of life and autonomy in these patients are disorders of walking and the balance. They are the leading cause of falls responsible for important medical, surgical and economic complications as well as a reactionary social isolation. The techniques of rehabilitation of walking to the subacute phase of a stroke are usually based on automatic walking.Off walking is a complex activity usually performed in everyday life in association with multiple tasks. It is therefore interesting to re-educate walking in dual task or even in multitasking.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: None (Open Label)
  • Study Primary Completion Date: May 10, 2023

Interventions

  • Other: rehabilitation multitasking walking.
    • rehabilitation multitasking walking.
  • Other: Traditional walking rehabilitation
    • Traditional walking rehabilitation

Arms, Groups and Cohorts

  • Experimental: multitasking walking
    • Multitasking Group: rehabilitation multitasking walking.
  • Active Comparator: walking simple task
    • Simple task group : Traditional walking rehabilitation

Clinical Trial Outcome Measures

Primary Measures

  • Measure walking speed
    • Time Frame: 6 months
    • Speed of the simple task of walking 10 meters testing.

Secondary Measures

  • Description of different types of walking disorders and balance in the subacute phase of stroke
    • Time Frame: inclusion
    • Currently no clinical scale exists in the literature at our knowledge. The walk of the patients will be qualitatively analyzed by the investigator in order to measure the prevalence of the different clinical categories of walking disorders according to their semiological characteristics
  • Score neuromotor the lower limb
    • Time Frame: 6 months
    • Score neuromotor the lower limb: Fugl Meyer
  • Dynamic equilibrium to TUG single and double cognitive task
    • Time Frame: 6 months
    • Dynamic equilibrium to TUG single and double cognitive task
  • Walking speed double cognitive task
    • Time Frame: 6 months
    • Walking speed double cognitive task
  • Executive functions: a battery of neuropsychological
    • Time Frame: 6 months
    • Executive functions: a battery of neuropsychological
  • Autonomy: FUNCTIONAL INDEPENDENCE MEASUREMENT
    • Time Frame: 6 months
    • Autonomy: FUNCTIONAL INDEPENDENCE MEASUREMENT
  • EVA Quality of life
    • Time Frame: 6 months
    • EVA (Visual Analogic Scale) quality of life
  • Correlation of cognitive gains with the gain of the walking speed of 10 meters
    • Time Frame: 6 months
    • Correlation of cognitive gains with the gain of the walking speed of 10 meters
  • anatomoclinical correlations
    • Time Frame: 6 months
    • Lesion score of gray matter and white matter (Volumetry on sequences 3DT1 and Flair) Cerebral

Participating in This Clinical Trial

Inclusion Criteria

  • Major: age between 18 and 90 years – Hospitalized for ischemic or hemorrhagic hemispheric stroke confirmed by CT or MRI <6months – walking disorder with the possibility of walking 10 meters with or without technical assistance (speed <1.2m / s) – verbal understanding with complex orders – Affiliates to social security Exclusion Criteria:

  • Brainstem stroke or cerebellar – Hypoacusia annoying understanding – Visual gene embarrassing awarding – severe aphasia: no understanding of complex orders – neurological or musculoskeletal history affecting walking – Participation in interventional research protocol in motor rehabilitation of the lower limb or cognitive – Patient under guardianship or deprived of liberty – pregnant women, parturient women or lactating (art L.1121-5)

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 90 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Centre Hospitalier Universitaire, Amiens
  • Collaborator
    • CENTRE DE REEDUCATION FONCTIONNELLE L’ESPOIR LILLE
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Sophie TASSEEL-PONCHE, Doctor, Study Director, CHU Amiens-Picardie France
    • Eric VERIN, professor, Principal Investigator, CHU de Rouen
    • Etienne ALLART, Doctor, Principal Investigator, CHRU de Lille
    • DEMAILLE Samantha, professor, Principal Investigator, CRF 4Espoir Lille
    • Valérie LECLERCQ-DONTGEZ, Doctor, Principal Investigator, Les 3 vallées
    • Haykal ELLEUCH, Doctor, Principal Investigator, CH Arras
    • Marie DECOCQ-DEMICHEL, Doctor, Principal Investigator, CH Le Belloy
    • Pascal RIGAUX, Doctor, Principal Investigator, CH Berck Sur Mer
    • Sabine POL-ROUX, Doctor, Principal Investigator, CH Compiègne
    • Sofiane LARIBI, Doctor, Principal Investigator, CH Breteuil
    • Skander MOALLA, Doctor, Principal Investigator, Centre Hospitalier de Beauvais
  • Overall Contact(s)
    • Sophie TASSEEL-PONCHE, Doctor, +33 322 455 735, tasseel-ponche.sophie@chu-amiens.fr

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.